Polartechnics moves into Pakistan
Monday, 09 March, 2009
Sydney’s Polartechnics has received another international order for its TruScreen cervical cancer screening technology, this time with Pakistan.
The Pakistani Government has initially ordered 100 units but expects to order more in the future.
TruScreen is a point of care detection device for cervical cancer. Cervical cancer is the fourth most common cancer in Pakistan, which has a female population of more than 85 million.
Last month, Polartechnics signed distribution agreements with major medical companies in Indonesia, Thailand, the Philippines and Sri Lanka.
Polartechnics also produces a self-administered HPV test called CerviScreen under a joint venture with Genera BioSystems and Gribbles Pathology.
The last mile of life sciences innovation
How do we translate technological possibility into meaningful real-world impact?
Machine learning uncovers patterns in DNA methylation
A new machine-learning method identifies differentially methylated DNA regions without sample...
HRT linked to lower dementia risk in some women
Hormone replacement therapy may reduce the risk of dementia — particularly for certain...
